1. Home
  2. MHD vs IRWD Comparison

MHD vs IRWD Comparison

Compare MHD & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock MuniHoldings Fund Inc.

MHD

Blackrock MuniHoldings Fund Inc.

HOLD

Current Price

$11.86

Market Cap

609.5M

Sector

Finance

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$4.06

Market Cap

520.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHD
IRWD
Founded
N/A
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
609.5M
520.6M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
MHD
IRWD
Price
$11.86
$4.06
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$6.12
AVG Volume (30 Days)
124.9K
7.2M
Earning Date
01-01-0001
02-26-2026
Dividend Yield
4.16%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.18
Revenue
N/A
$338,987,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.01
P/E Ratio
N/A
$22.47
Revenue Growth
N/A
N/A
52 Week Low
$9.92
$0.53
52 Week High
$12.18
$5.78

Technical Indicators

Market Signals
Indicator
MHD
IRWD
Relative Strength Index (RSI) 63.07 60.33
Support Level $11.62 $3.11
Resistance Level $11.77 $5.78
Average True Range (ATR) 0.09 0.34
MACD 0.02 0.04
Stochastic Oscillator 93.94 33.89

Price Performance

Historical Comparison
MHD
IRWD

About MHD Blackrock MuniHoldings Fund Inc.

Blackrock Muniholdings Fund Inc is a diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income taxes. The fund mainly invests its managed assets in municipal bonds rated investment grade or, if unrated, are deemed to be of comparable quality by the investment adviser at the time of investment. Its investment portfolio is mainly comprised of long-term municipal bonds with a maturity of more than ten years at the time of investment. The fund can also invest directly in such securities or synthetically through the use of derivatives.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: